Harpoon Therapeutics Q2 EPS $0.03 Up From $(0.53) YoY, Sales $20.22M Up From $8.30M YoY
Portfolio Pulse from Benzinga Newsdesk
Harpoon Therapeutics reported Q2 earnings of $0.03 per share, a 105.66% increase YoY. The company also reported $20.22 million in sales, a 143.54% increase YoY.
August 09, 2023 | 8:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Harpoon Therapeutics reported a significant increase in Q2 earnings and sales YoY. This could potentially lead to a positive impact on the stock price.
Harpoon Therapeutics reported a significant increase in both earnings and sales YoY. This indicates a strong financial performance, which is likely to be viewed positively by investors and could lead to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100